huahaipharm(SH:600521) Shang Hai Zheng Quan Bao·2025-12-30 23:22Core Viewpoint - The announcement details the results of the "Huahai Convertible Bond" repurchase option, indicating that no investors submitted repurchase requests during the designated period, resulting in no financial impact on the company [2][5][6]. Group 1: Repurchase Announcement - The repurchase period for the "Huahai Convertible Bond" was from December 22, 2025, to December 26, 2025 [2][4]. - The repurchase price was set at RMB 100.30 per bond, including current interest and tax [4][5]. - The company published multiple announcements regarding the repurchase from December 15 to December 26, 2025 [3]. Group 2: Repurchase Results - During the repurchase period, the effective number of repurchase requests was 0 bonds, resulting in a total repurchase amount of RMB 0 [2][5]. - As no repurchase requests were made, the company is not required to process any payments to investors [5]. Group 3: Impact of the Repurchase - The repurchase of the "Huahai Convertible Bond" will not affect the company's cash flow, asset status, or share capital [6]. - The unrepurchased bonds will continue to be traded on the Shanghai Stock Exchange [7].